Abstract:Breast cancer stands as the second leading cause of cancer-related deaths among women in the United States, with triple-negative breast cancer (TNBC) representing the most aggressive subtype. Although immune checkpoint inhibitors (ICI) demonstrated durable response in some TNBC patients, the added benefit of current FDA-approved ICI in combination with chemotherapy is estimated to be only around 10%. Fortunately, TNBC displays the highest number of tumor-infiltrating lymphocytes (TILs), compared to other BC subtypes, indicating an optimal context for the survival of T cells. Therefore, CAR-T therapy emerges as a promising therapeutic option for TNBC patients. Expanding the application of CAR-T therapies to solid tumors, including breast cancer, remains challenging. One of the key hurdles lies in the immunosuppressive tumor microenvironment, where the T cell receptor experiences long-term exposure to tumor antigens, leading to T cell exhaustion. This state impedes the T cells' capacity to efficiently target and eliminate cancer cells. Identifying key regulatory mechanisms downstream of the T cell receptor holds the potential to revolutionize existing immunotherapeutic strategies. In our study, we discovered that the presence of the master transcriptional factor of T cell stemness, TCF1, in CD8+ T cells, is essential for controlling TNBC tumors. TCF1 undergoes phosphorylation by LCK, a crucial component of initiating T cell receptor signaling, upon T cell activation. We found this phosphorylation site is indispensable for TCF1's transcriptional activities, inhibiting the downstream program of T-cell persistence and causing T-cell exhaustion. Reversing this process, either through LCK inhibition or introducing a non-phosphorylated form of TCF1, results in a more sustained CAR-T cell-mediated anti-tumor response. Our findings reveal the significance of TCF1 post-translational modification in the development and longevity of stem-like CD8+ T cells, bridging the gap between TCR signaling and transcriptional and epigenetic programs of stem-like CD8+ T cells. This insight contributes to a potential cure for TNBC by maintaining T cell persistence. Citation Format: Zhou Jiang, Yu-Yi Chu, Heng-Huan Lee, Mien-Chie Hung, Liuqing Yang, Chunru Lin. Revitalizing CAR-T cells for TNBC: Targeting phosphorylation of TCF7 to overcome T cell exhaustion [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 33.

Role of TCF-1 in differentiation, exhaustion, and memory of CD8+ T cells: A review

TCF‐1 maintains CD8+ T cell stemness in tumor microenvironment

Control of Lymphocyte Fate, Infection, and Tumor Immunity by TCF-1

Differentiation And Persistence Of Memory Cd8(+) T Cells Depend On T Cell Factor 1

The Transcription Factor Zfp335 Promotes Differentiation and Persistence of Memory CD8+ T Cells by Regulating TCF-1

The Transcription Factor TCF1 Preserves the Effector Function of Exhausted CD8 T Cells During Chronic Viral Infection

T Cell Signaling Targets for Enhancing Regulatory or Effector Function.

Dichotomous regulation of progenitor-like CD8 T cells during chronic viral infection by TCF1 and type I interferon

TCF1 dosage determines cell fate during T cell development

Exploring the Stage-Specific Roles of Tcf-1 in T Cell Development and Malignancy at Single-Cell Resolution.

Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction

The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer

T Cell Factor 1 Regulates Thymocyte Survival Via a RORγt-Dependent Pathway

T cell factor 1 (TCF-1) defines T cell differentiation in colorectal cancer

Tcf1 Sustains the Expression of Multiple Regulators in Promoting Early Natural Killer Cell Development

Tcf1 and Lef1 Are Required for the Immunosuppressive Function of Regulatory T Cells

Tcf1–CTCF Cooperativity Shapes Genomic Architecture to Promote CD8+ T Cell Homeostasis

A critical role for TCF-1 in T-lineage specification and differentiation

Abstract 33: Revitalizing CAR-T cells for TNBC: Targeting phosphorylation of TCF7 to overcome T cell exhaustion

Memory T Cells: Strategies for Optimizing Tumor Immunotherapy

ZBTB Transcription Factors: Key Regulators of the Development, Differentiation and Effector Function of T Cells